Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Clinical PK/PD study of TxA2 antagonist

July 28, 1997

Joint venture established for transgenic ATIII

July 25, 1997

Microbix receives milestone payment under ThromboClear agreement with Gensia

July 25, 1997

Novel fibrinogen/integrin receptor antagonists described by Merck KGaA

July 22, 1997

DuPont Merck prepares anticoagulant aminoboronic acids

July 21, 1997

Fibrinogen-antagonistic oxopiperazine derivatives from Yamanouchi

July 17, 1997

Potent, orally active fibrinogen antagonist developed at Merck & Co.

July 17, 1997

Texas Biotechnology initiates NDA filing for Novastan

July 16, 1997

Merck & Co. develops potent and selective pyridinone acetamide thrombin inhibitor

July 16, 1997

Lp(a)-dependent actions of LMWH

July 14, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...